home Resources and Services F.D.A. Revokes Approval of Avastin as Breast Cancer Drug F.D.A. Revokes Approval of Avastin as Breast Cancer Drug By Caryn Scoville Posted in Resources and Services Posted on November 18, 2011March 30, 2016 See full article in New York Times. Share this:Click to email a link to a friend (Opens in new window)Click to share on Twitter (Opens in new window)Click to share on Facebook (Opens in new window)Click to share on Tumblr (Opens in new window)Click to share on LinkedIn (Opens in new window)MoreClick to share on Pinterest (Opens in new window)Click to share on Pocket (Opens in new window)